Global Topical Corticosteroids Market – Industry Trends - Forecast to 2026

  • Pharmaceutical
  • Publish Reports
  • May 2019
  • Global
  • 355 Pages
  • No of Tables: 52
  • No of Figures: 330
Global Topical Corticosteroids Market By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Potency Class (Ultra-High, High,   Moderate, Mild), Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), Medication Type(Ointments, Creams, Liquid & Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), End-User(Hospital, Dermatology Clinics, Homecare, Others), Distribution Channel(Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), Purchase Mode(Over The Counter (Otc) Based, Prescription Based), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Topical Corticosteroids Market

Global Topical Corticosteroids Market is expected to rise from its initial estimated value of USD 3154.01million in 2018 to an estimated value of USD 4877.24 million by 2026, registering a CAGR of 5.6% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing prevalence of chronic disease or condition.

Market Definition: Global Topical Corticosteroids Market

Topical corticosteroids (steroids) is defined as a medications which is directly applied to the skin with intention to reduce irritation and inflammation, ; it is available in several different forms like ointments, gels, creams, lotions, mousses. They are available in four different potencies (strengths), known as mild, moderate, potent, and very potent

According to the CDC, in U.S 2 million people are infected with bacteria that are resistant to antibiotics, and at least 23,000 people die due to such infections. Increasing investment in research and development, act as a driver to the market.

Market Drivers

  • Growing number of geriatric population, this act as a driver to the market.
  • Growth in demand of topical drug delivery drugs, this act as a driver to the market.

Market Restraints

  • Expiry of patent for drugs, this act as restraints to the market.
  • Weak reimbursement policies, this act as restraints to the market.

Segmentation: Global Topical Corticosteroids Market

By Molecule Name

  • Fludroxycortide
  • Triamcinolone Acetonide
  • Fluocinolone Acetonide
  • Antiseptics
  • Betamethasone
  • Clobetasone Propionate
  • Clobetasone Butyrate
  • Halobetasone
  • Mometasone
  • Others

By Potency Class

  • Ultra High

    • Clobetasol Propionate
    • Diflorasone Diacetate
    • Betamethasone Dipropionate Glycol

  • High

    • Amcinonide
    • Betamethasone Dipropionate
    • Desoximetasone
    • Fluocinonide
    • Others

  • Moderate

    • Desoximetasone
    • Fluocinolone Acetonide
    • Fludroxycortide
    • Hydrocortisone Valerate
    • Triamcinolone Acetonide
    • Clobetasone Butyrate
    • Others

  • Mild

    • Hydrocortisone
    • Hydrocortisone Acetate
    • Betamethasone Valerate
    • Desonide
    • Fluocinolone Acetonide
    • Other

By Application

  • Acne
  • Dermatitis
  • Psoriasis
  • Skin Infection
  • Hyperpigmentation
  • Melasma
  • Others

By Medication Type

  • Ointments
  • Creams
  • Liquid & Solutions
  • Lotions
  • Gel
  • Oils
  • Pastes
  • Sprays
  • Others

By End User

  • Hospital
  • Dermatology Clinics
  • Homecare
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Pharmacy Stores
  • Online Pharmacies
  • Others

By Purchase Mode

  • Over The Counter (Otc) Based
  • Prescription Based

By Geography

  • North America

    • US.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Argentina
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • Middle East & Africa

    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In April 2019, ViiV Healthcare announced that they got approval from US Food and Drug Administration (FDA) to Dovato, the first, once-daily, single-tablet, two-drug regimen for treatment.
  • In April 2019, GSK receives approval from U.S related to Benlysta for intravenous use in children with lupus aged five years and above.

Competitive Analysis: Global Topical Corticosteroids Market

Global topical corticosteroids market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of topical corticosteroids market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Topical Corticosteroids Market

Few of the major competitors currently working in the topical corticosteroids market are GlaxoSmithKline plc. (UK), Merck Sharp & Dohme Corp. (US), LEO (Denmark), Almirall, S.A (Spain), Bausch Health (Canada), Cerecor, Inc., Sandoz International GmbH (Germany), Pfizer Inc. (US), Sanofi (France), AstraZeneca (UK), Almirall, LLC, Godetia Healthcare, Bayer AG, McKesson Medical-Surgical Inc., Regeneron (US), ALLERGAN (Ireland), Galderma laboratories (Switzerland), Novartis AG(Switzerland), and others

Research Methodology: Global Topical Corticosteroids Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global topical corticosteroids market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

TABLE OF CONTENTS GLOBAL TOPICAL CORTIOCOSTEROIDS MARKET

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY 1.2. MARKET DEFINITION 1.3. OVERVIEW OF GLOBAL TOPICAL CORTICOSTEROIDS MARKET 1.4. CURRENCY AND PRICING 1.5. LIMITATION 1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCES 2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION 3.1.2. GROWING NUMBER OF GERIATRIC POPULATION 3.1.3. GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS 3.1.4. INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT 3.1.5. NEW PRODUCT LAUNCHES BY KEY PLAYERS

3.2. RESTRAINTS

3.2.1. EXPIRY OF PATENT FOR DRUGS 3.2.2. WEAK REIMBURSEMENT POLICIES 3.2.3. STRINGENT REGULATORY POLICIES

3.3. OPPORTUNITIES

3.3.1. HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS 3.3.2. LUCRATIVE OPPORTUNITIES IN EMERGING MARKET 3.3.3. INCREASING MERGERS AND ACQUISITIONS

3.4. CHALLENGES

3.4.1. PRICING PRESSURE BY GOVERNMENT 3.4.2. SIDE EFFECTS OF TOPICAL CORTICOSTEROIDS

4. EXECUTIVE SUMMARY 5. PREMIUM INSIGHTS 6. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME

6.1. OVERVIEW 6.2. FLUDROXYCORTIDE 6.3. TRIAMCINOLONE ACETONIDE 6.4. FLUOCINOLONE ACETONIDE 6.5. ANTISEPTICS 6.6. BETAMETHASONE 6.7. CLOBETASONE PROPIONATE 6.8. CLOBETASONE BUTYRATE 6.9. HALOBETASONE 6.10. MOMETASONE 6.11. OTHERS

7. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS

7.1. OVERVIEW

7.2. ULTRA HIGH

7.2.1. CLOBETASOL PROPIONATE 7.2.2. DIFLORASONE DIACETATE 7.2.3. BETAMETHASONE DIPROPIONATE GLYCOL

7.3. HIGH

7.3.1. AMCINONIDE 7.3.2. BETAMETHASONE DIPROPIONATE 7.3.3. DESOXIMETASONE 7.3.4. FLUOCINONIDE 7.3.5. OTHERS

7.4. MODERATE

7.4.1. DESOXIMETASONE 7.4.2. FLUOCINOLONE ACETONIDE 7.4.3. FLUDROXYCORTIDE 7.4.4. HYDROCORTISONE VALERATE 7.4.5. TRIAMCINOLONE ACETONIDE 7.4.6. CLOBETASONE BUTYRATE 7.4.7. OTHERS

7.5. MILD

7.5.1. HYDROCORTISONE 7.5.2. HYDROCORTISONE ACETATE 7.5.3. BETAMETHASONE VALERATE 7.5.4. DESONIDE 7.5.5. FLUOCINOLONE ACETONIDE 7.5.6. OTHERS

8. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION

8.1. OVERVIEW 8.2. ACNE 8.3. DERMATITIS 8.4. PSORIASIS 8.5. SKIN INFECTION 8.6. HYPERPIGMENTATION 8.7. MELASMA 8.8. OTHERS

9. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE

9.1. OVERVIEW 9.2. OINTMENTS 9.3. CREAMS 9.4. LIQUID & SOLUTIONS 9.5. LOTIONS 9.6. GEL 9.7. OILS 9.8. PASTES 9.9. SPRAYS 9.10. OTHERS

10. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER

10.1. OVERVIEW 10.2. HOSPITAL 10.3. DERMATOLOGY CLINICS 10.4. HOMECARE 10.5. OTHERS

11. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL

11.1. OVERVIEW 11.2. HOSPITAL PHARMACIES 11.3. PHARMACY STORES 11.4. ONLINE PHARMACIES 11.5. OTHERS

12. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE

12.1. OVERVIEW 12.2. OVER THE COUNTER (OTC) BASED 12.3. PRESCRIPTION BASED

13. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS

13.1. OVERVIEW 13.2. BETNOVATE 13.3. BETNOVATE N 13.4. PANDERM PLUS 13.5. LOBATE 13.6. COSVATE G 13.7. CLOP G 13.8. TENOVATE GN 13.9. LOBATE GM 13.10. ULTIDERM 13.11. FLUTIVATE 13.12. FEXIN 13.13. MOMATE 13.14. CANDIDERM 13.15. OTHERS

14. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY

14.1. OVERVIEW

14.2. NORTH AMERICA

14.2.1. U.S. 14.2.2. CANADA 14.2.3. MEXICO

14.3. EUROPE

14.3.1. GERMANY 14.3.2. FRANCE 14.3.3. U.K. 14.3.4. ITALY 14.3.5. SPAIN 14.3.6. RUSSIA 14.3.7. TURKEY 14.3.8. BELGIUM 14.3.9. NETHERLANDS 14.3.10. SWITZERLAND 14.3.11. REST OF EUROPE

14.4. ASIA-PACIFIC

14.4.1. JAPAN 14.4.2. CHINA 14.4.3. INDIA 14.4.4. SOUTH KOREA 14.4.5. AUSTRALIA 14.4.6. SINGAPORE 14.4.7. THAILAND 14.4.8. MALAYSIA 14.4.9. INDONESIA 14.4.10. PHILIPPINES 14.4.11. REST OF ASIA PACIFIC

14.5. SOUTH AMERICA

14.5.1. BRAZIL 14.5.2. REST OF SOUTH AMERICA 14.6. MIDDLE EAST AND AFRICA 14.6.1. SOUTH AFRICA 14.6.2. REST OF MIDDLE EAST AND AFRICA

15. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE

15.1. COMPANY SHARE ANALYSIS: GLOBAL 15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA 15.3. COMPANY SHARE ANALYSIS: EUROPE 15.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

16. COMPANY PROFILES

16.1. GLAXOSMITHKLINE PLC.

16.1.1. COMPANY OVERVIEW 16.1.2. GLAXOSMITHKLINE PLC: REVENUE ANALYSIS 16.1.3. PRODUCT PORTFOLIO 16.1.4. RECENT DEVELOPMENTS

16.2. MERCK & CO. INC.

16.2.1. COMPANY OVERVIEW 16.2.2. MERCK & CO. INC.: REVENUE ANALYSIS 16.2.3. PRODUCT PORTFOLIO 16.2.4. RECENT DEVELOPMENTS

16.3. LEO PHARMA

16.3.1. COMPANY OVERVIEW 16.3.2. LEO PHARMA: REVENUE ANALYSIS 16.3.3. PRODUCT PORTFOLIO 16.3.4. RECENT DEVELOPMENTS

16.4. ALMIRALL S.A.

16.4.1. COMPANY OVERVIEW 16.4.2. ALMIRALL S.A.: COMPANY SNAPSHOT 16.4.3. PRODUCT PORTFOLIO 16.4.4. RECENT DEVELOPMENTS

16.5. VALEANT PHARMACEUTICALS INTERNATIONAL

16.5.1. COMPANY OVERVIEW 16.5.2. VALEANT PHARMACEUTICALS INTERNATIONAL: REVENUE ANALYSIS 16.5.3. PRODUCT PORTFOLIO 16.5.4. RECENT DEVELOPMENTS

16.6. ZYLERA PHARMACEUTICALS

16.6.1. COMPANY OVERVIEW 16.6.2. ZYLERA PHARMACEUTICALS: COMPANY SNAPSHOT 16.6.3. PRODUCT PORTFOLIO 16.6.4. RECENT DEVELOPMENTS

16.7. SANDOZ INTERNATIONAL GMBH

16.7.1. COMPANY OVERVIEW 16.7.2. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS 16.7.3. PRODUCT PORTFOLIO 16.7.4. RECENT DEVELOPMENTS

16.8. PFIZER INC.

16.8.1. COMPANY OVERVIEW 16.8.2. PFIZER INC.: REVENUE ANALYSIS 16.8.3. PRODUCT PORTFOLIO 16.8.4. RECENT DEVELOPMENTS

16.9. SANOFI S.A.

16.9.1. COMPANY OVERVIEW 16.9.2. SANOFI S.A.: COMPANY REVENUE ANALYSIS 16.9.3. PRODUCT PORTFOLIO 16.9.4. RECENT DEVELOPMENTS

16.10. ASTRAZENECA

16.10.1. COMPANY OVERVIEW 16.10.2. ASTRAZENECA: REVENUE ANALYSIS 16.10.3. PRODUCT PORTFOLIO 16.10.4. RECENT DEVELOPMENTS

17. RELATED REPORTS

TABLE LIST GLOBAL TOPICAL CORTIOCOSTEROIDS MARKET

TABLE 1 PRICE OF VARIOUS PRODUCTS CONTAINING TOPICAL CORTICOSTEROIDS AND ANTIMICROBIALS TABLE 2 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 3 GLOBAL FLUDROXYCORTIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 4 GLOBAL TRIAMCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 5 GLOBAL FLUOCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 6 GLOBAL ANTISEPTICS MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 7 GLOBAL BETAMETHASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 8 GLOBAL CLOBETASONE PROPIONATE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 9 GLOBAL CLOBETASONE BUTYRATE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 10 GLOBAL HALOBETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 11 GLOBAL MOMETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 12 GLOBAL OTHERS MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 13 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 14 GLOBAL ULTRA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 15 GLOBAL ULTRA HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 16 GLOBAL HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 17 GLOBAL HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 18 GLOBAL MODERATE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 19 GLOBAL MODERATE HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 20 GLOBAL MILD TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 21 GLOBAL MILD POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 22 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 23 GLOBAL ACNE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 24 GLOBAL DERMATITIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 25 GLOBAL PSORIASIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 26 GLOBAL SKIN INFECTION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 27 GLOBAL HYPERPIGMENTATION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 28 GLOBAL MELASMA TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 29 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS APPLICATION MARKET, BY REGION, 2015 – 2024 (USD BILLION) TABLE 30 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015– 2024 (USD MILLION) TABLE 31 GLOBAL OINTMENT TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 32 GLOBAL CREAMS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 33 GLOBAL LIQUID & SOLUTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 34 GLOBAL LOTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 35 GLOBAL GEL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 36 GLOBAL OILS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 37 GLOBAL PASTES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 38 GLOBAL SPRAYS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 39 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 40 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015– 2024 (USD MILLION) TABLE 41 GLOBAL HOSPITAL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 42 GLOBAL DERMATOLOGY CLINICS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 43 GLOBAL HOMECARE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 44 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 45 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 46 GLOBAL HOSPITAL PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 47 GLOBAL PHARMACY STORES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 48 GLOBAL ONLINE PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 49 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 50 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 51 GLOBAL OVER THE COUNTER (OTC)BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 52 GLOBAL PRESCRIPTION BASED TOPICAL CORTICOSTEROIDS MARKET,BY REGION, 2015 – 2024 (USD MILLION) TABLE 53 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 54 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015– 2024 (USD MILLION) TABLE 55 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 56 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 57 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 58 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 59 NORTH AMERICA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 60 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 61 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 62 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 63 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 64 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 65 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 66 U.S. TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 67 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 68 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 69 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 70 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 71 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 72 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 73 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 74 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 75 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 76 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 77 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 78 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 79 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 80 MEXICO TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 81 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 82 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 83 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015– 2024 (USD MILLION) TABLE 84 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 85 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 86 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 87 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 88 EUROPE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 89 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 90 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 91 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 92 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 93 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 94 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 95 GERMANY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 96 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 97 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 98 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 99 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 100 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 101 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 102 FRANCE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 103 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 104 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 105 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 106 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 107 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 108 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 109 U.K. TOPICAL CONTORTIONISTS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 110 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 111 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 112 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 113 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 114 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 115 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 116 ITALY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 117 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 118 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 119 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 120 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 121 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 122 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 123 SPAIN TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 124 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 125 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 126 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 127 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 128 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 129 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 130 RUSSIA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 131 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 132 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 133 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 134 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 135 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 136 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 137 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 138 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 139 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 140 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 141 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 142 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 143 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 144 BELGIUM TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 145 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 146 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 147 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 148 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 149 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 150 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 151 NETHERLANDS TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 152 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 153 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 154 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 155 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 156 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 157 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 158 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 159 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 160 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 161 REST OF EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 162 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 163 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 164 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 165 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 166 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 167 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 168 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 169 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 170 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 171 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 172 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 173 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 174 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 175 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 176 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 177 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 178 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 179 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 180 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 181 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 182 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 183 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 184 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 185 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 186 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 187 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 188 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 189 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 190 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 191 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 192 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 193 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 194 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 195 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 196 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 197 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 198 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 199 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 200 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 201 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 202 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 203 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 204 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 205 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 206 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 207 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 208 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 209 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 210 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 211 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 212 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 213 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 214 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 215 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 216 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 217 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 218 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 219 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 220 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 221 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 222 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 223 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 224 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 225 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 226 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 227 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 228 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 229 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 230 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 231 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 232 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 233 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 234 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 235 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 236 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 237 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 238 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 239 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 240 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 241 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015-2024,(USD MILLION) TABLE 242 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 243 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION) TABLE 244 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 245 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 246 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION) TABLE 247 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 248 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 249 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 250 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION) TABLE 251 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 252 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 253 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION) TABLE 254 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 255 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 256 REST OF SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 257 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015-2024,(USD MILLION) TABLE 258 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 259 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION) TABLE 260 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 261 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 262 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION) TABLE 263 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015-2024 (USD MILLION) TABLE 264 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 265 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 266 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION) TABLE 267 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 268 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 269 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION) TABLE 270 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015-2024 (USD MILLION) TABLE 271 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 272 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)

FIGURES LIST GLOBAL TOPICAL CORTIOCOSTEROIDS MARKET

FIGURE 1 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: SEGMENTATION FIGURE 2 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: DATA TRIANGULATION FIGURE 3 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: RESEARCH SNAPSHOT FIGURE 4 GLOBAL TOPICAL CORTICOSTEROIDS MARKET : BOTTOM UP APPROACH FIGURE 5 GLOBAL TOPICAL CORTICOSTEROIDS MARKET : TOP DOWN APPROACH FIGURE 6 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: INTERVIEW DEMOGRAPHICS FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL TOPICAL CORTICOSTEROIDS MARKET FIGURE 8 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR TOPICAL CORTICOSTEROIDS AND ASIA PACIFIC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD FROM 2017 TO 2024 FIGURE 9 INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION IS EXPECTED TO DRIVE THE MARKET FOR TOPICAL CORTICOSTEROIDS MARKET IN THE FORECAST PERIOD 2017 TO 2024 FIGURE 10 FLUDROXYCORTIDE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TOPICAL CORTICOSTEROIDS MARKET IN 2017 & 2024 FIGURE 11 ASIA PACIFIC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR TOPICAL CORTICOSTEROIDS MANUFACTURERS IN THE FORECAST PERIOD 2017 TO 2024 FIGURE 12 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY MOLECULE NAME, SNAPSHOT 2016 FIGURE 13 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY POTENCY CLASS, 2016 FIGURE 14 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY APPLICATION, 2016 FIGURE 15 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY MEDICATION TYPE, 2016 FIGURE 16 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY END-USER, 2016 FIGURE 17 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY DISTRIBUTION CHANNEL, 2016 FIGURE 18 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY PURCHASE MODE, 2016 FIGURE 19 GLOBAL TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) FIGURE 20 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016) FIGURE 21 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY GROGRAPHY (2017 & 2024) FIGURE 22 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016 & 2024) FIGURE 23 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME (2017 & 2024) FIGURE 24 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) FIGURE 25 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET : BY COUNTRY (2016) FIGURE 26 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2017 & 2024) FIGURE 27 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET BY COUNTRY (2016 & 2024) FIGURE 28 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME(2017 & 2024) FIGURE 29 EUROPE TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) FIGURE 30 EUROPE TOPICAL CORTICOSTEROIDS MARKET : BY COUNTRY (2016) FIGURE 31 EUROPE TOPICAL CORTICOSTEROIDS MARKET:BY COUNTRY (2017 & 2024) FIGURE 32 EUROPE TOPICAL CORTICOSTEROIDS MARKET BY COUNTRY (2016 & 2024) FIGURE 33 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME (2017 & 2024) FIGURE 34 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) FIGURE 35 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2016) FIGURE 36 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2017 & 2024) FIGURE 37 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET BY COUNTRY (2016 & 2024) FIGURE 38 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME (2017 & 2024) FIGURE 39 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) FIGURE 40 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2016) FIGURE 41 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2017 & 2024) FIGURE 42 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET BY COUNTRY (2016 & 2024) FIGURE 43 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET,BY MOLECULE NAME(2017 & 2024) FIGURE 44 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) FIGURE 45 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2016) FIGURE 46 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET:BY COUNTRY (2017 & 2024) FIGURE 47 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET BY COUNTRY (2016 & 2024) FIGURE 48 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME(2017 & 2024) FIGURE 49 GLOBAL TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) FIGURE 50 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) FIGURE 51 EUROPE TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) FIGURE 52 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART